Kombi-Kalz

Colecalciferol and calcium, the active ingredients in Kombi-Kalz, are a vitamin D3 and calcium supplement presented as an oral tablet for oral use. It helps prevent and treat vitamin D and calcium deficiencies in adults and children at risk of bone health problems.

GNH USA supplies Kombi-Kalz as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Kombi‑Kalz is used to address deficiencies in the vitamin D and calcium pathways, supporting bone health and mineral balance. - Vitamin D deficiency: restores adequate serum 25‑hydroxyvitamin D levels to support calcium absorption. - Calcium deficiency: provides elemental calcium to maintain normal serum calcium concentrations. - Osteoporosis risk: contributes to bone mineralization and helps reduce bone loss in individuals at risk.

Kombi‑Kalz may be associated with a range of adverse reactions, most of which are mild and reversible.

Common Side Effects: - Nausea: mild stomach upset after ingestion. - Constipation: reduced bowel movements. - Hypercalcemia symptoms: occasional fatigue or mild headache. - Metallic taste: transient alteration in taste perception. - Skin rash: mild erythema at the site of contact.

Serious or Rare Side Effects: - Severe hypercalcemia: confusion, arrhythmia, or renal impairment. - Allergic reaction: swelling of face, lips, or throat. - Kidney stones: due to excess calcium excretion. - Hypervitaminosis D: persistent vomiting, weakness, or high blood pressure.

Before using Kombi‑Kalz, consider the following safety measures. - Renal impairment: monitor serum calcium and vitamin D levels. - Hypercalcemia history: avoid if previously diagnosed with high calcium. - Sarcoidosis or granulomatous disease: use with caution due to altered vitamin D metabolism. - Pregnancy and lactation: consult a healthcare professional before use. - Drug interactions: review concomitant medications for calcium or vitamin D interactions. - Store at ambient temperature: keep below 25 °C, retain in original packaging, protect from moisture and direct sunlight.

Kombi‑Kalz can affect the absorption or activity of several medicines.

Major Interactions (Avoid): - Thiazide diuretics: may increase risk of hypercalcemia. - Digoxin: elevated calcium can enhance digoxin toxicity. - High‑dose vitamin A: synergistic hypercalcemia risk.

Moderate Interactions (Monitor Closely): - Antacids containing aluminum or magnesium: may reduce calcium absorption. - Orlistat: can decrease absorption of fat‑soluble vitamin D. - Corticosteroids: may counteract calcium and vitamin D benefits on bone.